Evidence map›Paper›PMID 41748696›Full record

ArticleScientific reports2026

Imputation methods for serologic biomarkers in inflammatory bowel disease.

Miad Boodaghidizaji, Dermot P B McGovern, Dalin Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Miad BoodaghidizajiF. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Dermot P B McGovernF. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Dalin LiF. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. dalin.li@cshs.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serologic biomarkers have emerged as a powerful tool for the diagnosis of Inflammatory Bowel Disease (IBD) and the differentiation between subgroups of IBD. However, missingness in serologic data can adversely affect the efficacy of any form of statistical or machine learning analysis, leading to biased predictions. This paper provides a thorough comparison of multiple imputation models that can be used for the imputation of serologic data under different missingness scenarios. All major forms of missingness, including Missing Completely at Random (MCAR), Missing at Random (MAR), and Missing Not at Random (MNAR), were explored in relation to the serologic data. The imputation models used in this study encompass Multiple Imputation (MI) using Chained Equations (MICE), Iterative Imputer (II), and Autoencoders (AE). Across three real IBD cohorts and 2,400 simulated scenarios spanning MCAR/MAR/MNAR and 5-40% missingness, we evaluated imputers on direct accuracy, inferential signal, and predictive utility. No single method is universally optimal: iterative imputers (II-BR/KNN/RF) tend to lead at low-moderate missingness, whereas autoencoder-based (AE/VAE) approaches are more robust as missingness increases; all analyses are performed within-cohort to avoid information leakage.

Indexed as

BiomarkersInflammatory Bowel DiseasesAlgorithmsAutoencoderHumansMachine LearningModels, StatisticalBiomarkersAutoencoderIBDImputationIterative ImputerMARMCARMICEMNARSerologic data

Identifiers

PMID41748696
PMCPMC13046806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.